SCHEMBL14021298

SCHEMBL14021298

CN(C)CCCN1CCN(C(=O)c2ccc(Nc3nccc(-c4ccc(Cl)cc4)n3)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 2/20 0.52
▸ CDK1 P06493 2/20 0.49
▸ CDK2 P24941 2/20 0.49
▸ JAK2 O60674 8/20 0.48
▸ JAK1 P23458 1/20 0.48
▸ AIMP2 Q13155 1/20 0.48
▸ JAK3 P52333 5/20 0.47
▸ MAPKAPK2 P49137 1/20 0.47
▸ IKBKB O14920 3/20 0.46
▸ CHUK O15111 2/20 0.46
▸ IKBKG Q9Y6K9 1/20 0.46
▸ PIK3CA P42336 2/20 0.46
▸ PIK3CB P42338 2/20 0.46
▸ PIK3CG P48736 2/20 0.46
▸ DRD2 P14416 1/20 0.45
▸ HDAC1 Q13547 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14021306 0.95 SYK (0.54) SYKCDK1CDK2JAK2JAK1
SCHEMBL14063843 0.90 IKBKB (0.47) SYKCDK1CDK2JAK2JAK3
SCHEMBL14021310 0.89 SYK (0.53) SYKCDK1CDK2JAK2AIMP2
SCHEMBL14021629 0.89 JAK2 (0.54) CDK1CDK2JAK2JAK1AIMP2
SCHEMBL14063895 0.88 SYK (0.50) SYKCDK1CDK2JAK2JAK3
SCHEMBL14021270 0.88 DRD2 (0.54) SYKCDK1CDK2JAK2JAK1
SCHEMBL14063849 0.88 PIK3CA (0.48) CDK1CDK2JAK2JAK1JAK3
SCHEMBL13590773 0.88 PIK3CA (0.47) CDK1CDK2JAK2JAK1AIMP2
SCHEMBL3049760 0.87 SYK (0.51) SYKCDK1CDK2JAK2JAK1
SCHEMBL14063914 0.87 SYK (0.52) SYKCDK1CDK2IKBKBCHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
Send feedback